Search

Your search keyword '"beta-Synuclein metabolism"' showing total 113 results

Search Constraints

Start Over You searched for: Descriptor "beta-Synuclein metabolism" Remove constraint Descriptor: "beta-Synuclein metabolism"
113 results on '"beta-Synuclein metabolism"'

Search Results

1. β-synuclein regulates the phase transitions and amyloid conversion of α-synuclein.

2. Exploring Intrinsic Disorder in Human Synucleins and Associated Proteins.

Catalog

Books, media, physical & digital resources

3. β-Synuclein Intermediates α-Synuclein Neurotoxicity in Parkinson's Disease.

4. Understanding Genetic Risks: Computational Exploration of Human β-Synuclein nsSNPs and their Potential Impact on Structural Alteration.

5. Cell-specific localization of β-synuclein in the mouse retina.

6. Retinal ganglion cell type-specific expression of synuclein family members revealed by scRNA-sequencing.

8. Differential involvement of amyloidogenic evolvability in oligodendropathies; Multiple Sclerosis and Multiple System Atrophy.

9. Interneuronal In Vivo Transfer of Synaptic Proteins.

10. Phosphodiesterase 10A deactivation induces long-term neurological recovery, Peri-infarct remodeling and pyramidal tract plasticity after transient focal cerebral ischemia in mice.

11. Exploring the brain metabolic correlates of process-specific CSF biomarkers in patients with MCI due to Alzheimer's disease: preliminary data.

12. Synuclein Analysis in Adult Xenopus laevis .

13. Synaptic vesicle binding of α-synuclein is modulated by β- and γ-synucleins.

14. Comparing the copper binding features of alpha and beta synucleins.

15. β-Synuclein: An Enigmatic Protein with Diverse Functionality.

16. β-synuclein potentiates synaptic vesicle dopamine uptake and rescues dopaminergic neurons from MPTP-induced death in the absence of other synucleins.

17. Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity.

18. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.

19. Dopamine promotes the neurodegenerative potential of β-synuclein.

20. Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.

21. Systematic review of gene expression studies in people with Lewy body dementia.

22. Possible Role of Amyloidogenic Evolvability in Dementia with Lewy Bodies: Insights from Transgenic Mice Expressing P123H β-Synuclein.

23. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis.

24. Quantitative Profiling of Synuclein Species: Application to Transgenic Mouse Models of Parkinson's Disease.

25. Increased Dynamics of α-Synuclein Fibrils by β-Synuclein Leads to Reduced Seeding and Cytotoxicity.

26. Age-related distribution and potential role of SNCB in topographically different retinal areas of the common marmoset Callithrix jacchus, including the macula.

27. Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion.

28. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration.

29. Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy.

30. Interactions between the Intrinsically Disordered Proteins β-Synuclein and α-Synuclein.

31. Multi-Pronged Interactions Underlie Inhibition of α-Synuclein Aggregation by β-Synuclein.

32. Pla2g6 Deficiency in Zebrafish Leads to Dopaminergic Cell Death, Axonal Degeneration, Increased β-Synuclein Expression, and Defects in Brain Functions and Pathways.

33. Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.

34. Immature-like molecular expression patterns in the hippocampus of a mouse model of dementia with Lewy body-linked mutant β-synuclein.

35. Comparative Analysis of the Conformation, Aggregation, Interaction, and Fibril Morphologies of Human α-, β-, and γ-Synuclein Proteins.

36. Age-related Beta-synuclein Alters the p53/Mdm2 Pathway and Induces the Apoptosis of Brain Microvascular Endothelial Cells In Vitro.

37. Accumulation of beta-synuclein in cortical neurons is associated with autophagy attenuation in the brains of dementia with Lewy body patients.

38. Levels of α- and β-synuclein regulate cellular susceptibility to toxicity from α-synuclein oligomers.

39. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.

40. A pH-dependent switch promotes β-synuclein fibril formation via glutamate residues.

41. Bioinorganic Chemistry of Parkinson's Disease: Affinity and Structural Features of Cu(I) Binding to the Full-Length β-Synuclein Protein.

42. Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays.

43. FTY720 (Fingolimod) reverses α-synuclein-induced downregulation of brain-derived neurotrophic factor mRNA in OLN-93 oligodendroglial cells.

44. β-Synuclein suppresses both the initiation and amplification steps of α-synuclein aggregation via competitive binding to surfaces.

45. Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

46. Yeast reveals similar molecular mechanisms underlying alpha- and beta-synuclein toxicity.

47. The loss of inhibitory C-terminal conformations in disease associated P123H β-synuclein.

48. Copper(I/II), α/β-Synuclein and Amyloid-β: Menage à Trois?

49. Fish Synucleins: An Update.

50. Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein.